Home > Insider Trading > Filing (0001144204-14-008735)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335103	Protea Biosciences Group Inc.	NONE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529365	Scott Segal	955 Hartman Run Road Morgantown WV 26507		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock")	Acquisiton	2011-12-27	50,000	$2.00	1,569,123	No	4	P	Direct
Common Stock	Acquisiton	2013-07-23	388,038	$0.50	1,957,161	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2011-12-27	25,000	$0.00	25,000	$2.25
Common Stock	Warrant	Acquisiton	2013-07-23	291,029	$0.00	291,029	$1.10
Common Stock	Convertible Notes	Disposition	2013-07-23	388,038	$194,019.00	0	$0.50
Common Stock	Stock Option	Acquisiton	2008-05-30	100,000	$150,000.00	100,000	$1.50
Common Stock	Stock Option	Acquisiton	2013-03-22	218,750	$120,313.00	218,750	$0.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
933,334	2011-12-27	2016-12-27	No	4	P	Direct
1,224,363	2013-06-30	2018-07-23	No	4	P	Direct
1,224,363	2013-07-23	2013-07-23	No	4	C	Direct
1,324,363	2008-05-30	2018-05-30	No	4	A	Direct
1,209,779	2013-03-22	2023-03-22	No	4	A	Direct

Footnotes

On December 27, 2011 (the "December Closing Date"), the Company issued to Scott Segal (the "Reporting Person") one unit (the "Unit"), consisting of 50,000 shares of the Company's common stock, at a price of $2.00 per share, and a warrant (the "Warrant") to purchase 25,000 shares of Common Stock at an exercise price of $2.25 per share.
On April 16, 2012, the Company issued a Convertible Promissory Note to the Reporting Person in the aggregate principal amount of $100,000. On September 25, 2012 the Company issued a convertible promissory note to the Reporting Person in the aggregate principal amount of $75,000. On March 22, 2013, the Company approved a reduction in the conversion price to $0.50 per share. On June 30, 2013, pursuant to the terms and conditions of a Conversion Agreement, dated June 18, 2013, outstanding principal and interest equal to $194,019 was converted into 388,038 shares of common stock.
Pursuant to the Conversion Agreement, upon conversion of the April Note and September Note, the Company agreed to issue a warrant to purchase 75% of the number of shares into which the notes are convertible.
Represents shares vested as of February 10, 2014.
Reflects the expiration of previously reported warrants to purchase 333,334 shares of common stock held by the Reporting Person.